Condoiu, C.; Musta, M.; Cumpanas, A.A.; Bardan, R.; Dema, V.; Zara, F.; Suciu, C.S.; Dumitru, C.-S.; Ciucurita, A.; Dumache, R.;
et al. Spontaneous Necrosis of a High-Risk Bladder Tumor Under Immunotherapy for Concurrent Malignant Melanoma: Role of BRAF Mutations and PD-L1 Expression. Biomedicines 2025, 13, 377.
https://doi.org/10.3390/biomedicines13020377
AMA Style
Condoiu C, Musta M, Cumpanas AA, Bardan R, Dema V, Zara F, Suciu CS, Dumitru C-S, Ciucurita A, Dumache R,
et al. Spontaneous Necrosis of a High-Risk Bladder Tumor Under Immunotherapy for Concurrent Malignant Melanoma: Role of BRAF Mutations and PD-L1 Expression. Biomedicines. 2025; 13(2):377.
https://doi.org/10.3390/biomedicines13020377
Chicago/Turabian Style
Condoiu, Cristian, Mihael Musta, Alin Adrian Cumpanas, Razvan Bardan, Vlad Dema, Flavia Zara, Cristian Silviu Suciu, Cristina-Stefania Dumitru, Andreea Ciucurita, Raluca Dumache,
and et al. 2025. "Spontaneous Necrosis of a High-Risk Bladder Tumor Under Immunotherapy for Concurrent Malignant Melanoma: Role of BRAF Mutations and PD-L1 Expression" Biomedicines 13, no. 2: 377.
https://doi.org/10.3390/biomedicines13020377
APA Style
Condoiu, C., Musta, M., Cumpanas, A. A., Bardan, R., Dema, V., Zara, F., Suciu, C. S., Dumitru, C.-S., Ciucurita, A., Dumache, R., Ismail, H., & Novacescu, D.
(2025). Spontaneous Necrosis of a High-Risk Bladder Tumor Under Immunotherapy for Concurrent Malignant Melanoma: Role of BRAF Mutations and PD-L1 Expression. Biomedicines, 13(2), 377.
https://doi.org/10.3390/biomedicines13020377
